Ardelyx (ARDX) Long-Term Investments (2020)

Ardelyx (ARDX) posted Long-Term Investments of $2.1 million for Q4 2020.

Ardelyx (ARDX) Long-Term Investments (2020) Analysis & Trends

Ardelyx's Long-Term Investments history runs 1 years deep, the most recent figure standing at $2.1 million for Q4 2020.

Quarterly Long-Term Investments changed N/A year-over-year to $2.1 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.1 million (changed N/A YoY) and the FY2020 annual result came in at $2.1 million, changed N/A from the prior year.
Long-Term Investments was $2.1 million for Q4 2020 at Ardelyx.
Across five years, Long-Term Investments topped out at $2.1 million in Q4 2020 and bottomed at $2.1 million in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	505,194.89
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	5.75 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	9.79 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Ardelyx	1.26 Bn	1.02 Bn	89.66 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	2.11 Mn